| Revenue | DKK 1,7M | -47% |
| EBITDA | DKK 1,7M | -47% |
| Net profit | DKK 174K | -84% |
| Total assets | DKK 33,4M | -1% |
| Equity | DKK 13,8M | +674% |
| Employees | — | — |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 261 | 478 | 508 | 467 | 425 | 3.170 | 1.679 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 261 | 478 | 508 | 467 | 425 | 3.170 | 1.679 |
| Depreciation & amort. | -51 | -51 | -1.494 | -51 | -51 | -337 | -368 |
| EBIT | 210 | 427 | -986 | 416 | 374 | 2.833 | 1.312 |
| Net financials | -49 | -244 | -291 | -310 | -521 | -1.485 | -1.089 |
| Profit before tax | 160 | 183 | -1.278 | 106 | -147 | 1.348 | 223 |
| Tax | 18 | 41 | -281 | 23 | -32 | 275 | 49 |
| Net profit | 142 | 142 | -996 | 83 | -115 | 1.073 | 174 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 3.803 | 10.055 | 8.888 | 9.241 | 34.003 | 33.743 | 33.398 |
| Equity | 1.591 | 1.733 | 737 | 819 | 704 | 1.778 | 13.752 |
| Long-term debt | 1.532 | 1.453 | 1.334 | 1.263 | 1.161 | 15.993 | 14.851 |
| Short-term debt | 313 | 6.493 | 6.435 | 6.768 | 31.613 | 15.158 | 3.875 |
| Total debt | 1.845 | 7.947 | 7.768 | 8.031 | 32.774 | 31.151 | 18.726 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TC Management | Management | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PHARMPROTECH HOLDING ApS | Company | 100.0% | 100.0% | 2018 |
| Person | Role here | Other companies |
|---|---|---|
| Tony Christensen | Management | 0 companies |